BackAclaris Therapeutics Overview

Aclaris Therapeutics Goodwill

Track Aclaris Therapeutics's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average

Loading

Aclaris Therapeutics Goodwill History

Loading

Aclaris Therapeutics vs. peers: Goodwill Comparison

Loading

Aclaris Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aclaris Therapeutics (ACRS) FAQ

As of the most recent data (March 2026), ACRS shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACRS's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Aclaris Therapeutics is outperforming or lagging.

Tracking ACRS's goodwill over time shows whether Aclaris Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Aclaris Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Aclaris Therapeutics's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.